Press release
Cystic Fibrosis 2017 Europe Market Expected to Grow at CAGR 35.10% and Forecast to 2019
Cystic Fibrosis SWOT Analysis And ForecastAbout Cystic Fibrosis
Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited disease. The primary symptoms of cystic fibrosis include high salt content in the sweat, breathing difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic fibrosis is one of the most common genetic disorders observed in Caucasian children. Rare diseases are those that affect less than 5 patients per 10,000, as defined in the EU by Rare Disease UK. Cystic fibrosis is therefore classified under rare diseases. The incidence of cystic fibrosis varies between populations. It is significantly less common in Asian and African populations compared to Caucasians (people from Europe, North America, and Australasia), with a marked difference between each country in those regions. Precise data regarding the prevalence of cystic fibrosis in Europe is not available, but it is estimated to be 1 in 8,000-10,000 individuals. Cystic fibrosis is a chronic disease and is usually progressive in nature. The onset of cystic fibrosis typically occurs in early childhood or, rarely, at birth. The principal manifestations of cystic fibrosis in patients are chronic bronchitis, pancreatic insufficiency, adolescent diabetes, pancreatitis, male sterility, and very rarely intestinal obstruction or liver cirrhosis. The mortality and morbidity of patients are dependent on the degree of bronchopulmonary involvement.
TechNavio's analysts forecast the Cystic Fibrosis market in Europe to grow at a CAGR of 35.10 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Cystic Fibrosis market in Europe for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of cystic fibrosis including:
• Small Molecules
• Biologics
TechNavio's report, Cystic Fibrosis Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers data from Europe; it also covers the market landscape of the Cystic Fibrosis market in Europe and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/38459-cystic-fibrosis-market-in-europe-2015-2019
Key Vendors
• Actavis
• F. Hoffmann-La Roche
• Gilead Sciences
• Novartis
• Vertex Pharmaceuticals
Other Prominent Vendors
• Abbott
• Anthera Pharmaceuticals
• Arcturus Therapeutics
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Corbus Pharmaceuticals
• Genzyme
• Insmed
• Johnson & Johnson
• Merck Sharp & Dohme
• Neovii Biotech
• Novo Nordisk
• PharmaSwiss
• Pharmaxis
• Proteostasis Therapeutics
• PTC Therapeutics
• United Medical
• Venus Remedies
Market Driver
• Unmet Needs
• For a full, detailed list, view our report
Market Challenge
• High Cost of Treatments
• For a full, detailed list, view our report
Market Trend
• Rise in Public Awareness
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
Complete Report Details @ https://www.wiseguyreports.com/reports/38459-cystic-fibrosis-market-in-europe-2015-2019
Table Of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Product Profiles
05.1.1 Zenpep
05.1.2 Colomycin/Colobreathe
05.1.3 Pulmozyme
05.1.4 Cayston
05.1.5 TOBI/TOBI Podhaler
05.1.6 Kalydeco
06. Introduction
07. Disease Overview
07.1 Understanding the Disease
07.2 Pathophysiology
07.3 Epidemiology
07.3.1 Global
07.3.2 UK
07.4 Diagnosis
07.4.1 Carrier Testing
07.4.2 Antenatal Testing
07.4.3 Newborn Screening
07.4.4 Other Tests
07.5 Manifestations of Cystic Fibrosis
07.6 Economic Burden
08. Pipeline Portfolio
09. Market Landscape
09.1 Market Overview
09.2 Market Size and Forecast
09.3 Five Forces Analysis
10. Segmentation of Cystic Fibrosis Market in Europe by Molecule Type
10.1 Biologics
10.1.1 Enzymes
10.2 Small Molecules
10.2.1 CFTR Modulators
10.2.2 Antibiotics
11. Segmentation of Cystic Fibrosis Market in Europe by Route of Administration
11.1 Oral
11.2 Parenteral
11.3 Topical
12. Segmentation of Cystic Fibrosis Market in Europe by Dosage Form
12.1 Solid
12.2 Liquid
13. Key Leading Countries
13.1 UK
13.2 France
13.3 Italy
13.4 Germany
13.5 Spain
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
Continued…….
Buy This Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=38459
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Address:
WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cystic Fibrosis 2017 Europe Market Expected to Grow at CAGR 35.10% and Forecast to 2019 here
News-ID: 533729 • Views: …
More Releases from WGR Consultants
Report on Global Automotive Adaptive Lighting Market Competition, Status and For …
WiseGuyReports has announced the addition of “Global Automotive Adaptive Lighting Market Professional Survey Report 2017 ” that provides the market survey of Automotive Adaptive Lighting. The research report presents a comprehensive overview of market and growth trends of this industry in the coming years.
Overall Automotive Adaptive Lighting factual study report gives an all-around examination of the Automotive Adaptive Lighting market and its key assessment and predictions for the…
Report on Global Wooden Floor Market Competition, Status and Forecast, Market Si …
Wooden Floor SWOT Analysis And Forecast 2022
This report studies Wooden Floor in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Armstrong
Mannington
Mohawk
Pergo
Shaw Industries
Anderson Hardwood Floors
Mullican Flooring
Giorio
Beaulieu International Group
Kahrs Group
Kaindl Flooring
Nature…
Global Ballast Water Treatment Market 2017 Research Methodology of Top Key Playe …
Ballast Water Treatment SWOT Analysis & Forecast 2022
Ballast Water Treatment Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
The report firstly introduced the Ballast Water Treatment basics: definitions, classifications, applications…
Specialty Wire 2017 Global Market Key Players – MWS Wire, Torpedo Specialty Wi …
Specialty Wire SWOT Analysis And Forecast 2022
This report studies Specialty Wire in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
MWS Wire
Torpedo Specialty Wire
Specialty Wire and Cable (SWC)
LANOCO Specialty…
More Releases for Cystic
Cystic Fibrosis Market Report-Growth with Industry Study, Detailed Analysis | Cy …
The research study contains an in detail descriptive overview and analysis of the Cystic Fibrosis Market, a summary of the market shares constituted by each component, the annual growth of each sector, and the revenue potential of the section. In addition, Cystic Fibrosis Market production and consumption data are used to determine the geographical features.
Get FREE PDF sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3639856
Top Company Profile Analysis in this Report-
Cystic Fibrosis…
The Cystic Fibrosis Market to Witness Robust Growth Due to Increasing Cases of C …
Cystic fibrosis is a rare, progressive, life-threatening disease results in the formation of thick mucus that builds up in the lungs, digestive tract, and other parts of the body. If left untreated, it leads to severe digestive and respiratory problems as well as other complications such as infections and diabetes. According to the Cystic Fibrosis Foundation, more than 70,000 people are living with cystic fibrosis around the world. As the…
Cystic Fibrosis Market Opportunity Analysis, 2018-2026
Cystic fibrosis (CF) is a genetic disorder that usually affects the lungs and may also affect the pancreas, kidneys, liver, and intestine. Long-term repercussions including difficulty in breathing and coughing as a result of recurrent lung infections can be seen in CF. Some of the other signs and symptoms include sinus infections, poor growth, infertility in males, fatty stool, and guild of the fingers and toes. Different individuals may have…
Cystic Fibrosis Therapeutics Market Research Reports 2017
This report studies sales (consumption) of Cystic Fibrosis Therapeutics in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Vertex Pharmaceuticals , F. Hoffmann-La Roche , AbbVie , Gilead Science , Novartis , AstraZeneca , Bayer , Celtaxsys , Pharmaxis , ProQR Therapeutics , PTC Therapeutics…
Cystic Fibrosis - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Cystic Fibrosis - Heat Map and Analysis to its growing collection of premium market research reports.
Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body’s epithelial cells, and result in…
Cystic Fibrosis - Heat Map And Analysis
MarketResearchReports.Biz is providing you Latest Market Research report of "Cystic Fibrosis - Heat Map And Analysis".
Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body?s epithelial cells, and result in the buildup of a thick and sticky mucus in the lungs…
